Insight & Intelligence

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

April 15, 2010 (Vol. 30, No. 8)

Viral Safety Methods for Manufacturing

Designing Proper Procedures to Protect Both Potential Patients and Cell-Line Production

  • The growing significance of biotherapeutics, particularly monoclonal antibodies (mAbs), assures that increased demand for virus-safety products and services will continue, despite the trend toward a more risk-based approach to virus removal and inactivation. Virus safety is one component of world-wide regulatory guidelines requiring biomanufacturers to demonstrate that their ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.